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Introduction {#sec1}
============

Respiratory syncytial virus (RSV) is a ubiquitous viral pathogen that infects nearly all children before 2 years of age ([@bib29]). It is estimated that RSV causes more than 60,000 in-hospital deaths per year in children less than 5 years old, with the majority of deaths occurring in developing regions ([@bib70]). In addition, RSV infection can lead to serious complications in the elderly and high-risk adults and causes a disease burden similar to non-pandemic influenza A in these populations ([@bib23]). Currently, the only clinical intervention for RSV is passive prophylaxis with the monoclonal antibody Synagis, which reduces RSV-related hospitalization ([@bib76]). However, the high cost and moderate efficacy of Synagis restrict its use to high-risk infants in developed regions of the world ([@bib35], [@bib69], [@bib76]). Thus, there is great interest in developing more effective therapeutic agents for RSV, including small-molecule antivirals.

RSV is an enveloped, negative-sense, single-stranded RNA virus that belongs to the *Pneumoviridae* family ([@bib3]). Only three viral proteins are absolutely required for replication of the RSV genome: the nucleoprotein (N), the large protein (L), and the phosphoprotein (P) ([@bib32], [@bib83]). N associates with viral RNA to form a tightly woven helical assembly that protects the RNA from cellular nucleases and recognition by the innate immune system ([@bib5], [@bib75]). L harbors three conserved enzymatic domains: the RNA-dependent RNA polymerase (RdRp) domain, the polyribonucleotidyl transferase (PRNTase or capping) domain, and the methyltransferase (MTase) domain, which catalyzes cap methylation. These activities are all potential targets for inhibitor development. Nucleoside analogs that terminate RNA chain synthesis have been identified ([@bib12], [@bib17], [@bib81]), and one such compound, ALS-8176, has shown efficacy in RSV-infected adults ([@bib19]). Several non-nucleoside small-molecule inhibitors have also been identified ([@bib13], [@bib24]), and although some (for example, BI-compound D) are known to disrupt RNA cap addition ([@bib42]), there are additional inhibitor classes for which the mechanism of action is not well understood ([@bib20], [@bib51]).

P serves as an essential polymerase cofactor that tethers L to the nucleoprotein-RNA complex ([@bib27], [@bib32], [@bib83]). P also acts as a chaperone that prevents the association of nascent N (N^0^) with host cell RNAs ([@bib26], [@bib56], [@bib77]) and is responsible for recruiting the M2-1 protein, a processivity factor that is required for efficient transcription of viral RNA ([@bib6], [@bib14], [@bib50]). In addition, P recruits the cellular phosphatase PP1 to inclusion bodies to regulate viral transcription ([@bib62]). Thus, P plays critical roles in regulating RNA replication and transcription through its interactions with multiple proteins. Structurally, RSV P contains a central oligomerization domain that is predicted to form a tetrameric coiled coil ([@bib10], [@bib44]). Regions N- and C-terminal to the oligomerization domain are predicted to be intrinsically disordered and may only adopt defined conformations when bound to other proteins. The dynamic nature of RSV P has prevented determination of its structure ([@bib56], [@bib71]); thus, the molecular mechanisms by which P coordinates the activities of diverse viral components are not well understood.

To gain atomic-level information regarding RSV transcription and replication, we initiated structural studies of a purified polymerase complex comprising L and P. The resulting 3.2-Å cryoelectron microscopy (cryo-EM) structure reveals that P displays unique structural plasticity, with each monomer adopting a different conformation as it interacts with distinct regions on L. The variability in secondary structure of each P monomer indicates that this viral phosphoprotein exhibits characteristics of a "transformer" protein ([@bib38]). In addition, the surface on the RSV L RdRp domain that is recognized by RSV P is similar to the region bound by the ribosomal S1 protein cofactor on the RdRp of the distantly related Qβ bacteriophage polymerase, indicating that this interaction may be evolutionarily conserved. Our results also provide the first structural description of the RdRp and capping domains of RSV L and provide insights into the mechanism of viral escape from nucleoside analog and non-nucleoside inhibitors. Collectively, these results inform our understanding of viral polymerase complexes and should aid in the development of next-generation inhibitors of RSV infection.

Results {#sec2}
=======

RSV L Co-expressed with RSV P Is Biochemically Active {#sec2.1}
-----------------------------------------------------

Human RSV L was co-expressed with RSV P in Sf9 cells. The purified protein was analyzed by size exclusion chromatography, and SDS-PAGE analysis confirmed the presence of both L (∼250 kDa) and P (∼40 kDa) in the final sample ([Figure 1](#fig1){ref-type="fig"} A). Densitometric analysis and known oligomeric states of the proteins suggested a stoichiometry of 1:4 (L:P). To verify that the L-P complex was functional, RdRp activity was measured in an RNA template-dependent primer-extension assay. In the presence of GTP, ATP, and α^33^P-CTP, L-P incorporated 67-fold more α^33^P-CTP into the growing primer than what was detected in the control reaction ([Figure 1](#fig1){ref-type="fig"}B). L-P activity was also measured in a nucleotide-incorporation assay. When incubated with ^33^P-GTP, the polymerase incorporated one ^33^P-GMP (+1) into the primer ([Figure 1](#fig1){ref-type="fig"}C, lane a). With the addition of ^33^P-GTP and ATP, the enzyme extended the primer by three nucleotides (+3), GAA, complementary to the RNA template ([Figure 1](#fig1){ref-type="fig"}C, lane b). When incubated with ^33^P-GTP, ATP, and CTP, the enzyme extended the primer by seven nucleotides (+7), GAACAAA ([Figure 1](#fig1){ref-type="fig"}C, lane c). As a control, RSV L-P added only four nucleotides (+4) when incubated with ^33^P-GTP, ATP, and ALS-8112-TP, the active form of a known RSV polymerase nucleoside inhibitor that causes chain termination ([Figure 1](#fig1){ref-type="fig"}C, lane d) ([@bib17]). The non-processive, abortive pattern of nucleotide addition and the chain termination property of ALS-8112-TP observed with RSV L-P was consistent with results reported previously ([@bib17]), indicating that the recombinant RSV L-P has RNA-dependent RNA polymerase activity.Figure 1The Recombinant RSV L-P Complex Is Biochemically Active(A) SDS-PAGE of the purified L-P complex. Molecular weights (in kilodaltons) of the ladder are shown on the left, and the L and P bands are labeled on the right.(B) RNA synthesis activity of the RSV L-P complex was tested in a primer extension assay using an 11-mer RNA template and biotinylated 4-mer RNA primer. Primers were captured on streptavidin-coated plates, and extension was measured by incorporation of α^33^P-CTP. Bars indicate the mean, and error bars depict the SD of one independent experiment with 16 technical replicates (∗p \< 0.001, Mann-Whitney *U* test).(C) Polyacrylamide sequencing gel showing the results of the nucleotide incorporation assay for a single nucleotide (lane a) and multiple nucleotides (lanes b--d). ALS-8112-TP is a CTP analog that terminates elongation.(D) Transfer of tritiated methyl groups from S-adenosyl methionine (SAM) molecules to a set of synthetic RNAs of varying length (5-, 9-, and 15-mers) that mimic the 5′ end of RSV mRNA was measured using a filter-binding assay. Bars indicate the mean, and error bars depict the SD of four independent experiments. Asterisks indicate means that were statistically different from that of the control sample as measured by Dunnett's test (p \< 0.001).

Because the L protein harbors multiple enzymatic domains, we sought to further validate the recombinant RSV L-P protein by measuring its MTase activity. The transfer of tritiated methyl groups from S-adenosyl methionine (SAM) to synthetic RNA molecules derived from the 5′ end of RSV mRNA was measured using a filter-binding assay. The L-P protein exhibited MTase activity for three synthetic GpppG RNAs of different lengths, with activity 7- to 10-fold higher than a control reaction lacking the synthetic RNAs ([Figure 1](#fig1){ref-type="fig"}D). Collectively, these results indicated that the recombinant L-P complex was functionally active and suitable for structural analysis by cryo-EM.

Determination of the 3.2-Å Cryo-EM Structure of RSV L in Complex with Tetrameric P {#sec2.2}
----------------------------------------------------------------------------------

The L-P complex was plunge-frozen on UltrAuFoil 1.2/1.3 grids ([@bib66]), and a dataset was collected using a Titan Krios equipped with a K2 Summit detector ([Figure S1](#figs1){ref-type="fig"} ; [Table 1](#tbl1){ref-type="table"} ). After motion correction, contrast transfer function (CTF) estimation, 2D classification, and iterative rounds of heterogeneous 3D refinement, a total of 241,669 particles remained. Homogeneous 3D refinement of this particle stack resulted in a 3.4-Å map. After initial building of the L model and docking of the closely related human metapneumovirus (hMPV) P oligomerization domain structure into the map ([@bib39]), it was possible to identify the portions of the density that corresponded to the P monomers. We then generated a map in which these regions were deleted. A low-pass filter was applied to this new map as well as to the original map, and both were used as input volumes for a final round of heterogenous 3D refinement to remove particles in which the tetrameric P had dissociated. The resulting stack of 196,720 RSV L-P particles was subjected to a homogeneous, non-uniform 3D refinement that yielded the final 3.2-Å map. The low sequence identity of vesicular stomatitis virus (VSV) L prevented use of the VSV L structure ([@bib41]) as a starting model, but this structure was used to guide manual building of RSV L. Although the sharpened map was used for the majority of model building, the C-terminal portions of two P monomers were difficult to place in this map because of over-sharpening. However, these regions were visible in the unsharpened maps; therefore, both maps were used in combination to build these regions of the polymerase complex.Figure S1Cryo-EM Data Processing, Related to [Figure 2](#fig2){ref-type="fig"}Flow chart shows the data processing scheme used to obtain the 3.2 Å resolution map for the RSV L--P complex. A cutout of the cryo-EM map is shown as gray transparent density and the model built into the density is shown as blue sticks with oxygen and nitrogen atoms colored red and blue, respectively. The graph shows the FSC curves used to calculate the resolution of the final reconstruction with the FSC cutoff that was used (0.143) shown as a dotted line. Local resolution estimation was performed with MonoRes ([@bib79]). Scale bar = 500 Å.Table 1Cryo-EM Data Collection and Validation StatisticsData Collection and ProcessingEMDBEMD-20536MicroscopeFEI Titan KriosMagnification22,500Pixel size (Å)1.075Voltage (kV)300DetectorGatan K2 SummitExposure (e^−^/Å^2^)48Defocus range (μm)−1.5 to −2.5Final particles196,720SymmetryC1Resolution (Å)3.2**Model Refinement and Validation**PDB ID6PZK**Model Composition**Non-hydrogen atoms13,153RMSD bonds (Å)0.012RMSD angles (°)1.94**Ramachandran**Favored (%)96.2Allowed (%)3.8Outliers (%)0Rotamer outliers (%)1.95MolProbity score1.09EM Ringer score2.6

A total of 1,361 residues of L (residues Asn11--Leu133, Thr184--Gly618, Arg627--Ser658, and Asn690--Glu1460) were built into the 3.2-Å map ([Figure 2](#fig2){ref-type="fig"} ). Based on homology with the VSV L structure, residues 1--968 belong to the RdRp domain, and residues 969--1460 belong to the PRNTase (capping) domain. Although the MTase domain, connector domain (CD), and C-terminal domain (CTD) of our construct were present when analyzed by SDS-PAGE after size exclusion chromatography, and the protein exhibited MTase activity *in vitro*, these domains were not visible in our map ([Figure S2](#figs2){ref-type="fig"} ). This finding is not unexpected, however, given that the related VSV L is known to sample multiple states in which these three domains display various degrees of association with the RdRp and PRNTase domains ([@bib60]). In addition to the L core, we could build portions of four discrete monomers of P, ranging in length from 53--98 residues. The longest monomer of P spans residues 131--228, corresponding to the oligomerization domain and most of the C-terminal region of P.Figure 2Structure of the RSV L Core Bound to Tetrameric PRSV L is shown in ribbons colored in cool colors, and each monomer of tetrameric P is shown in ribbons colored in a unique warm color. The RNA-dependent RNA polymerase domain (RdRp) is colored dark blue, and the polyribonucleotidyltransferase (PRNTase) domain is shown in light blue. The linear maps show the portions of L (top) and P (bottom) that are resolved in the structure as colored bars. The connector domain (CD), methyltransferase domain (MTase) and C-terminal domain (CTD) of L are not observed in the structure. Arrows denote conserved residues required for function. NTD, N-terminal domain; OD, oligomerization domain. The linear schematics for L and P are not drawn to scale. See also [Figure S1](#figs1){ref-type="fig"}, [Figure S2](#figs2){ref-type="fig"}, [Figure S4](#figs4){ref-type="fig"}.Figure S2The CD, MTase, and CTD Are Absent in the Cryo-EM Map, Related to [Figure 2](#fig2){ref-type="fig"}(A) The model built for the L protein core of RSV and (B) the published structure of VSV L ([@bib41]) are shown as ribbons colored in cool colors. The connector domain (CD), methyltransferase domain (MTase) and C-terminal domain (CTD) are colored white for VSV and are not observed in the RSV structure. The linear map shows the portions of L that are resolved in the RSV structure as colored bars.

The RSV P Tetramer Grips L Using an Unusual Tentacular Arrangement {#sec2.3}
------------------------------------------------------------------

As expected from previous experiments, residues 131--151 of RSV P formed a tetrameric coiled coil ([@bib10], [@bib43], [@bib56]). Historically, regions outside of this oligomerization domain have not been structurally well characterized because of their intrinsic flexibility ([@bib46]). However, the interaction of P with L stabilized ordered conformations of the C-terminal regions of P, allowing them to be resolved for the first time. Perhaps the most striking feature of the tetrameric P structure is the large degree of variation in the conformation of each of the four P monomers ([Figure 3](#fig3){ref-type="fig"} ) (P~1~, P~2~, P~3~, and P~4~). These different conformations allow P to wrap around the RdRp of L in a tentacular fashion ([Figure 4](#fig4){ref-type="fig"} ). Although P~1~ and P~4~ make extensive contacts with L, P~3~ makes minimal contacts with L, and P~2~ interacts almost exclusively with the other P monomers. The unique organization adopted in this complex allows a relatively small region of P (less than 100 residues) to contact more than 11 regions of the primary L sequence and bury more than 4,000 Å^2^ of surface area on L ([Figures 4](#fig4){ref-type="fig"}A and 4B).Figure 3The RSV P Tetramer Wraps around L in a Tentacular FashionRSV L is shown as a white molecular surface, and P monomers are shown as ribbons. The P~4~ monomer is colored as a rainbow (blue to red, N to C terminus, respectively). All other monomers are colored to match P~4~.See also [Figures S6](#figs6){ref-type="fig"} and [S7](#figs7){ref-type="fig"}.Figure 4Two Phosphoprotein Monomers Contact Three Discrete Regions on the RdRp Domain of RSV L(A) RSV L and P are colored as in [Figure 2](#fig2){ref-type="fig"} but are rotated by 90° about the vertical axis. The three windows represent the views shown in (C), (D), and (E).(B) L and P are shown as molecular surfaces colored by electrostatic potential from red to blue, negative to positive, respectively. The surface of each is shown in an open-book representation. The approximate binding interface is outlined in yellow and black. A region of electrostatic complementarity is highlighted with a dashed oval.(C) Magnified view of the P~1~--L interaction.(D) Magnified view of the P~4~--L interaction.(E) Magnified view of the C-terminal P~4~-L interaction.Side chains involved in hydrogen bonds, salt bridges, or hydrophobic interactions are shown as sticks, with oxygen and nitrogen atoms colored red and blue, respectively. Hydrogen bonds and salt bridges are depicted as black dashed lines. See also [Figure S3](#figs3){ref-type="fig"}, [Figure S5](#figs5){ref-type="fig"}, [Figure S6](#figs6){ref-type="fig"}.

The interaction of P with L is driven by a number of hydrophobic and electrostatic interactions ([Figure 4](#fig4){ref-type="fig"}B). The majority of electrostatic interactions are made between residues 167--179 of P~1~ and the RdRp domain of L. Two positively charged P~1~ residues, Arg167 and Arg174, form salt bridges with L residues Asp718 and Glu722 ([Figure 4](#fig4){ref-type="fig"}C). In addition, two negatively charged residues on P~1~, Glu176 and Glu179, form salt bridges with Arg523 and Lys529 on L. We predict that mutation of these residues would disrupt the L-P interaction and decrease the activity of L. Consistent with this hypothesis, two of these charged P residues (Arg174 and Glu176) have been shown previously to be critical for the activity of L in a minigenome assay ([@bib47]). In addition, a temperature-sensitive virus with an E176G substitution in P reverted the glycine to a negatively charged residue when the virus was passaged at physiological temperatures ([@bib47]). The RSV L-P structure thus provides a molecular explanation for the decreased activity of L because of these substitutions in P.

The P~4~ monomer, for which the largest number of residues could be built, contacts a completely different set of L residues than P~1~. Two residues on P~4~ (Ile181 and Leu198) form a hydrophobic cap above Phe452 on the β6 strand of L ([Figure 4](#fig4){ref-type="fig"}D). Additionally, a region of P~4~ forms a β-hairpin that hydrogen-bonds with β6 of L to form a small β sheet ([Figure 4](#fig4){ref-type="fig"}D). In P~1~ and P~2~, these same residues are within an α helix, and in P~3~, they are disordered, indicating that the conformation of this region of P is particularly malleable. Furthermore, at the base of the loop connecting the β strands of the P~4~ hairpin, Arg163 forms a salt bridge with Glu765 of L, and the main chain of Gly165 forms a hydrogen bond with Tyr772 of L ([Figure 4](#fig4){ref-type="fig"}D). The C-terminal region of P~4~ makes additional contacts with L, including hydrogen bonds between Asn217 of P and Asn362 and Thr365 of L, as well as hydrophobic interactions between Leu223 of P and surrounding hydrophobic residues on L ([Figure 4](#fig4){ref-type="fig"}E). Leu223, along with Leu216 and Leu227, are three hydrophobic residues on the C terminus of P shown previously to contribute to L binding. Mutation of these residues disrupts polymerase activity ([@bib72]), demonstrating that these interactions between L and P, which are critical for function of the polymerase, can be explained by the structure presented here.

In addition to the contacts made between P and L, extensive interactions between P monomers are also present. Contacts within the oligomerization domain were expected ([@bib10], [@bib43], [@bib56]), but the structure reveals that interactions between P monomers also occur outside of the oligomerization domain. The C-terminal α helices of P~2~ and P~3~ rest on top of P~1~ to form a three-helix bundle ([Figure 4](#fig4){ref-type="fig"}A). In this arrangement, Ala169, Ile173, and Ile178 of P~1~ are capped by hydrophobic residues on P~2~ and P~3~. To validate the importance of these residues as well as of those described above, we generated a panel of 37 variants of P in which one or two residues were mutated to alanine and tested these variants in a minigenome replication assay. Variants with substitutions of residues between position 131 and 189 as well as position 205 showed less than 20% of the activity observed for wild-type P ([Figure S3](#figs3){ref-type="fig"} ). For the P variants with reduced activity, 16 of the substitutions mapped to regions involved in formation of the coiled coil in the oligomerization domain, 8 were in regions involved in the interaction between P and L, and 8 mapped to residues involved in the interactions between P~1~, P~2~, and P~3~ that lie outside of the oligomerization domain. Collectively, these results demonstrate that the multifaceted interactions of P identified here are critical for its function in viral replication.Figure S3Residues Involved in P-L and P-P Contacts Are Critical for Polymerase Function, Related to [Figure 4](#fig4){ref-type="fig"}BSRT7/5 cells ([@bib9]) were transfected with plasmids encoding the wild-type (WT) N, M2-1 and L proteins, the pMT/Luc minigenome, and WT or mutant P proteins, together with pCMV-βGal for transfection standardization. Viral RNA synthesis was quantified 24 h after transfection by measuring the luciferase activity after cell lysis. Each luciferase minigenome activity value was normalized based on β-galactosidase expression and is the mean of three independent experiments performed in triplicate. Error bars show standard deviations. The dotted line indicates 20% of wild-type activity. The color used to label each variant indicates the likely function of each residue based on the L--P structure.

Conserved Features of the RSV RdRp Domain {#sec2.4}
-----------------------------------------

The RNA-dependent RNA polymerases of negative-sense RNA viruses contain four subdomains---the palm, fingers, thumb, and a subdomain thought to serve as a structural support ([Figure 5](#fig5){ref-type="fig"} A)---and six conserved sequence motifs (motifs A--F) ([@bib36], [@bib58]). The majority of these motifs are found in the palm subdomain ([Figure 5](#fig5){ref-type="fig"}B), which is composed of two α helices (α29 and α30) and a β sheet comprising 5 strands (β9, β12, β13, β14, and β15). A conserved glycine residue (Gly877) just after the motif E β sheet connects the palm and thumb subdomains and may allow the palm domain to exhibit small degrees of motion relative to the thumb, as demonstrated for the enterovirus polymerase ([@bib31]; [Figure 5](#fig5){ref-type="fig"}B). Motif B forms one of two connections that are present between the palm and fingers. This motif is composed of a flexible loop that extends from the finger subdomain into the α29 helix of the palm. The presence of a glycine just before the α29 helix is known to be critical for catalysis in the RdRps of hepatitis C and encephalomyocarditis viruses ([@bib45], [@bib67]). RSV harbors two additional glycine residues that form a GGxxG motif also found in the RdRp domains of L proteins from hMPV, Ebola, VSV, and other non-segmented negative-sense RNA viruses ([Figure S4](#figs4){ref-type="fig"} ). Thus, the palm subdomain is framed on either side by glycine residues that likely aid in flexibility of this region to accommodate the template RNA and incoming nucleoside triphosphates (NTPs) in the catalytic site ([@bib28]).Figure 5Structure of the RSV L RdRp Domain(A) The RdRp domain is shown in ribbons, with the fingers in blue, the thumb in green, the palm in red, and the remaining structural support of the RdRp domain in white. The dashed circle highlights the Gly-Asp-Asn (GDN) motif, with the Asp and Asn side chains shown as sticks.(B) The same view as in (A), but with sequence motifs A--F highlighted in rainbow colors. The Cα atoms of conserved glycine residues are shown as spheres.(C) Magnified view of the active site, colored as in (B). Select residues are shown as sticks, with oxygen atoms colored red, nitrogen atoms colored blue, and sulfur atoms colored yellow. The Cα atoms of conserved glycine residues are shown as spheres. The panel on the right shows the same view, but with a UTP molecule modeled based on alignment of the palm subdomain active site with the hepatitis C virus RNA polymerase structure (PDB: [1NB6](pdb:1NB6){#intref0075}).(D) The same region as in (C), rotated by 180° to show three residues on motif B that are mutated in viruses that escape inhibition by ALS-8176.See also [Figure S5](#figs5){ref-type="fig"}.Figure S4Amino Acid Sequence Alignment of L Proteins, Related to [Figure 2](#fig2){ref-type="fig"}The amino acid sequences of L from RSV strain A2 (P28887), human metapneumovirus (Q91L20), Zaire ebolavirus strain Mayinga-76 (Q05318) and vesicular stomatitis virus Indiana strain (P03523.2) were aligned using ESPript ([@bib63]). Secondary structure for RSV L is shown above the sequences.

The conserved catalytic motif (Gly810-Asp811-Asn812 \[GDN\]) of the RdRp is situated on the loop that connects β12 with β13 in motif C ([Figure 5](#fig5){ref-type="fig"}C). Another catalytic residue, Asp700, is located in motif A on the β9 strand. Together, Asp811, Asn812, and Asp700 are responsible for coordinating the two magnesium ions required for catalysis of phosphodiester bond formation ([@bib53]). In our map, no density for magnesium ions is observed, but this may be due to the resolution or lack of magnesium during purification. A conserved aromatic residue, Phe704, is located in motif A on the α26 helix ([Figure 5](#fig5){ref-type="fig"}C). The side chain of Phe704 is oriented away from the active site and toward the α helix of Motif B, where it is neighbored by three hydrophobic residues (Leu701, Phe708, and Trp785). The presence of an aromatic residue at position 704 is well conserved, but it was previously unclear whether this residue is required for nucleotide binding in the active site or for stability of the L protein ([@bib36]). The RSV L-P structure suggests the latter.

The majority of the RSV RdRp finger subdomain is α-helical, but a small β sheet composed of β7, β8, and β10 contains the final motif required for polymerase activity (motif F) ([Figure 5](#fig5){ref-type="fig"}B). Although a portion of the density in this region is disordered in our map and prevented us from building residues 609--626, the base of the β7--β8 hairpin and the Arg627 side chain are visible and positioned to interact with negatively charged phosphate groups in the active site ([Figure 5](#fig5){ref-type="fig"}C). In addition to its role in coordinating the template strand and the incoming NTP for catalysis, the finger subdomain also interacts with the structural subdomain to form an electropositive pore that likely serves as the entry point for incoming NTPs ([Figure S5](#figs5){ref-type="fig"} ), similar to what has been described for other viral polymerases ([@bib11], [@bib48], [@bib74]).Figure S5Positively Charged Channels on the RSV L Core, Related to [Figure 5](#fig5){ref-type="fig"}L is shown as molecular surfaces colored by electrostatic potential (positive in blue, negative in red). Arrows highlight two positively charged channels. The right panel is the same as the left, but is rotated 30° about the vertical axis with the white regions of the molecular surface sliced away to clearly show the pores. Based on comparison to other RdRp structures, the two pores are proposed to accommodate an incoming NTP and the RNA template, with the opening at the top of the protein leading to the methyltransferase domain.

Viral Escape from a Nucleoside Analog Inhibitor Likely Occurs by an Allosteric Mechanism {#sec2.5}
----------------------------------------------------------------------------------------

Viral escape from the nucleoside inhibitor ALS-8176 has been mapped to the so-called "Quad" substitutions in RSV L (M628L/A789V/L795I/I796V) ([@bib17]). The RSV L-P structure reveals that three of these residues are buried on the α29 helix of Motif B, oriented away from the active site of the polymerase, with one of the residues (A789V) in close proximity to Phe704 of motif A ([Figure 5](#fig5){ref-type="fig"}D). Previous reports have suggested that the Quad substitutions act by increasing the ability of the RdRp to discriminate the altered structure of the cytidine analog from that of cytidine, preventing its incorporation into the growing RNA ([@bib18]). Our structure suggests that the A789V, L795I, and I796V substitutions act allosterically by altering the conformation of the polymerase active site without directly contacting either native NTPs or the cytidine analog. This is consistent with the finding that motif B is involved in sensing the correct NTP and allosterically regulating the activity of the RdRp ([@bib28]).

The RSV L PRNTase Domain Adopts a Non-initiation Conformation {#sec2.6}
-------------------------------------------------------------

The PRNTase domain of RSV L is responsible for the addition of a 5′ cap to nascent viral mRNAs ([@bib8]). In addition, the PRNTase domain contains the priming loop (1267--1282), which is thought to facilitate *de novo* initiation ([@bib41]). In the structure determined here, the priming loop is flipped upward away from the RdRp domain ([Figures 6](#fig6){ref-type="fig"}A and 6B), removed from the RdRp active site. This is in contrast to what was observed previously in the VSV L structure, in which the priming loop reached out of the PRNTase domain toward the RdRp active site ([Figure 6](#fig6){ref-type="fig"}B; [@bib41]). For the VSV L structure, the authors suggested that the conformation observed represents the initiation state and that the priming loop as well as the CD, MTase, and CTD domains would need to reorient for elongation to occur. The alternate positioning of the priming loop in the RSV L structure, combined with the lack of observable density for the CD, MTase, and CTD domains, suggests that the structure determined here may resemble an elongation conformation of RSV L.Figure 6Structure of the RSV L PRNTase Domain(A) The RSV L protein is shown as ribbons, with the RdRp domain in white and the PRNTase domain in light blue. The PRNTase domain of VSV L is aligned to that of RSV L and shown as purple ribbons.(B) View defined by the box shown in (A). The priming loop and connecting regions are shown as ribbons colored light blue (RSV) and purple (VSV). Two threonine residues are shown as sticks. The Cα atoms of the conserved glycine residues of the GxxT motif are shown as spheres.(C) The same view as in (A) but with conserved sequence motifs of the PRNTase domain highlighted in unique colors.(D) Magnified view of the active site, colored as in (C). The Cα atoms of conserved glycine residues are shown as spheres. Transparent molecular surfaces are shown for two tyrosine residues, Tyr1331 and Tyr1336.(E) View of two residues, Leu1421 and Ile1381, involved in viral escape from BI-D. A pocket near the PRNTase active site is shown as a transparent surface.(F) View of the region surrounding Glu1269.(G) View of the region surrounding the α helix that is mutated in temperature-sensitive viruses.In all panels, select residues are shown as sticks, with oxygen and nitrogen atoms colored red and blue, respectively, and hydrogen bonds depicted as dashed lines.

Sequence analysis of the L proteins of non-segmented, negative-sense RNA viruses has identified several conserved residues in the PRNTase domain that have also been assigned motifs (motifs A--E) ([@bib40], [@bib52]). In RSV L, these residues are clustered around the center of the cavity formed between the RdRp and PRNTase domains ([Figure 6](#fig6){ref-type="fig"}C). Motif D (also referred to as the His-Arg or HR motif) consists of two catalytic residues that are critical for cap formation: His1338 and Arg1339 ([@bib8]). The position of the priming loop in the RSV L structure results in a distance between motif D and motif B (also called the GxxT motif) of less than 5 Å ([Figure 6](#fig6){ref-type="fig"}D). Thus, flipping of the priming loop into a position likely associated with elongation is coupled with closing of the active site of the PRNTase domain into a compact conformation. Gly1264 marks the point around which the priming loop hinges ([Figure 6](#fig6){ref-type="fig"}B), and a variant with a substitution to a less flexible amino acid (alanine) at this position has been shown previously to have defects in initiation of replication, elongation of viral RNA, and cap addition ([@bib8]). Collectively, these data suggest that motion of the priming loop is critical for all three processes, consistent with biochemical data that has demonstrated crosstalk between RNA synthesis and capping ([@bib8], [@bib52]).

In addition to Gly1264, Trp1262 may also play a role in positioning the priming loop ([Figure 6](#fig6){ref-type="fig"}D). The presence of an aromatic residue at this position is conserved in L proteins from multiple non-segmented, negative-sense RNA viruses ([Figure S4](#figs4){ref-type="fig"}), likely because of hydrophobic interactions with residues N-terminal to motif E. However, the precise identity of this residue is not conserved, and the tolerance for different hydrophobic residues at this position depends on the viral background ([@bib52]). The RSV L structure reveals that a hydrogen bond between the indole group of Trp1262 and the hydroxyl group of Ser1390 may help to anchor motif B and motif D together to form the PRNTase active site. In VSV L, the Trp-Ser interaction is replaced with a hydrogen bond that is formed between Tyr1152 and Gln1270. Thus, although Trp1262 is not conserved across viruses, the interaction between these two regions is structurally preserved.

Viral Escape from a Non-nucleoside Inhibitor {#sec2.7}
--------------------------------------------

The non-nucleoside small-molecule inhibitor BI-compound D (BI-D) disrupts RNA cap addition, but its binding site on RSV L is currently unknown. Viruses that escape inhibition by BI-D harbor mutations encoding one of three substitutions in residues surrounding the PRNTase active site (I1381S, L1421F, or E1269D) ([@bib42]). Ile1381 and Leu1421 are in close proximity to one another on the surface of L. Ile1381 contributes to a small pocket on the surface of the PRNTase domain that includes motifs B, D, and E ([Figure 6](#fig6){ref-type="fig"}E). Although Leu1421 does not form a part of the cavity wall, it contacts Ile1381, and a substitution to the larger phenylalanine side chain may indirectly alter the shape of this pocket through its interaction with Ile1381. The location of these residues near a surface-exposed pocket within the active site of the PRNTase domain suggests that this pocket could be the binding site of BI-D.

The substitution present in the third escape variant occurs at Glu1269, which is approximately 20 Å away from Ile1381 and Leu1421. Glu1269 forms hydrogen bonds with three residues on L (Thr1341, Lys1294, and Trp1297), anchoring the priming loop to motif C ([Figure 6](#fig6){ref-type="fig"}F). In this conformation, Glu1269 is oriented away from the PRNTase active site. Substitution of Glu1269 with the shorter aspartate residue present in the escape mutant would disrupt this hydrogen bonding network and likely change the conformation of the priming loop. This change would be expected to affect the organization of the proposed BI-D binding site because Motif B contributes to the surface pocket and is located on the priming loop, just two residues from Glu1269. Thus, it seems unlikely that Glu1269 directly contacts BI-D, and the structure suggests that the E1269D substitution results in allosteric changes to the BI-D binding site.

A Temperature-Sensitive L Mutant Would Likely Have an Altered Motif D Conformation {#sec2.8}
----------------------------------------------------------------------------------

A number of live-attenuated RSV vaccine candidates have mutations in L that render the virus temperature sensitive. One virus, called cpts530/1030, has been used as a background strain for engineering viruses with high levels of attenuation and genetic stability ([@bib82]). The "1030" mutation in this virus refers to a substitution (Y1321N) that is located on α50 in the PRNTase domain, between motif C and the catalytic motif D. In the RSV L structure, Tyr1321 forms a hydrogen bond with Lys1305 on α49. This bond may help lock the position of these two α helices relative to one another but likely could not form with the shorter side chain of an asparagine residue ([Figure 6](#fig6){ref-type="fig"}G). The catalytic residues of motif D, as well as two aromatic residues (Tyr1331 and Tyr1336) that stack on either side of Trp1297 of motif C, are both located on the loop just C-terminal to α50. Motion of α50 away from α49 would be expected to disrupt the interaction of Tyr1331 and Tyr1336 with Trp1297 and alter the conformation of the loop that contains the catalytic residues. It is likely that the temperature sensitivity of the 1030 mutant virus is due to destabilization of this region, which can be compensated by growth at reduced temperatures. Mutational analysis has also demonstrated that, although the Y1321N substitution moderately attenuates viral replication in a mouse model of infection, insertion of a negatively charged residue into this position (Y1321E) results in more dramatic attenuation ([@bib49]). There are several negatively charged residues present on α48 and α49 that would repel a negatively charged residue if it were present on α50; thus, this substitution would be expected to have a more dramatic effect on the relative orientation of these three α helices.

Discussion {#sec3}
==========

Replication and transcription of negative-sense RNA viruses rely on specialized RNA-dependent RNA polymerases that must be carried within the virus. These RdRps are essential for viral survival and are structurally dissimilar to host-cell polymerases, making them excellent targets for antivirals. To efficiently replicate and transcribe viral RNA, RdRps typically require one or more cofactors. Although understanding the interactions between viral polymerases and their cofactors can provide additional targets for inhibitor development, structural characterization of these interactions has often proven difficult. The structure presented here provides the first structural characterization of a viral phosphoprotein in complex with a viral L protein. The phosphoprotein of viruses in the *Mononegavirales* order are generally composed of an N-terminal domain, a central oligomerization domain, and a C-terminal domain and are known to tether multiple viral components to a centralized area where viral replication occurs ([@bib15]). Interactions with viral proteins have primarily been mapped to the N- and C-terminal domains, which are thought to be intrinsically disordered, but are capable of transiently adopting α-helical arrangements in solution or when bound to other proteins ([@bib56], [@bib68]). Previous work has indicated that this structural plasticity is required for RSV P function ([@bib54]). Intrinsically disordered proteins are thought to adopt "fuzzy" structures in which flexibility is retained even when these proteins interact with other binding partners ([@bib4]). The regions of P that are not contacting L are not visible in our cryo-EM map, indicating that unliganded P is indeed dynamic. However, we show that regions of P can become ordered when bound to L and that the same residues of P monomers can adopt distinct conformations, indicating that RSV P shares properties with the "transformer" proteins ([@bib38]). This class of protein has also been identified in the Ebola virus, which uses different oligomeric states of the VP40 protein to assemble the viral matrix layer and to regulate viral transcription ([@bib7]). The ability to utilize one protein for multiple interactions via structural transformations helps maximize the efficiency of viruses with limited genome sizes, and our results suggest that this might be a common phenomenon among RNA viruses.

For VSV L, an N-terminal fragment of the P was sufficient to favor the formation of a compact structure in which the CD, MTase, and CTD domains packed against the core of L ([@bib41], [@bib61]). However, VSV P was not clearly visible in the cryo-EM map obtained for the VSV L-P complex. In contrast, the RSV L-P structure described here shows that the oligomerization domain and C-terminal region of P, rather than the N-terminal region, interact with L. The P sequences of these two viruses vary substantially, and the region of VSV P used to stabilize the VSV L structure has low sequence homology to RSV P ([Figure S6](#figs6){ref-type="fig"} ). These results suggest that the mechanisms by which P influences the structural organization of L may differ between RSV and VSV.Figure S6Amino Acid Sequence Alignment of Phosphoproteins, Related to [Figure 3](#fig3){ref-type="fig"}The amino acid sequences of P from RSV strain A2 (P03421), bovine RSV strain A51908 (P33454), ovine RSV strain WSU 83-1578 (Q83956), murine pneumonia virus strain 15 (Q5MKM7), human metapneumovirus (Q8B9Q8), avian metapneumovirus isolate Canada goose/Minnesota/15a/2001 (Q2Y2M5), and vesicular stomatitis virus Indiana strain (P03520) were aligned and displayed using ESPript ([@bib63]). The secondary structure for the P~4~ monomer is shown above the sequences. Both the oligomerization domain (residues 125--155) and regions in the C-terminal domain (156--190) are well conserved among pneumoviruses.

The results of our structural analysis allow us to update the interaction map that has been generated for RSV P ([@bib56]). Although structural studies have defined the interaction of M2-1 ([@bib68]) and N^0^ ([@bib22], [@bib26]) with N-terminal peptides of RSV P, interactions in the oligomerization domain and C-terminal region are less well understood. Biochemical data have implicated P residues 216--239 in binding to L ([@bib72]); however, the RSV L-P structure and minigenome assay results presented here demonstrate that, although these residues are important for binding to L, contacts between L and P are more extensive than previously thought and include the oligomerization domain and surrounding regions, particularly the charged residues from 167--179. It has also been suggested that the nucleocapsid and L binding sites on P may overlap ([@bib47], [@bib56], [@bib72]). Because the four different P monomers adopt different conformations and make unique contacts with L, it is possible that P could be bound simultaneously by L and nucleocapsid, with different monomers mediating the distinct interactions with each. Determining whether simultaneous binding of L and nucleocapsid occurs by such a mechanism will likely require structural information for the entire replication complex.

Although the sequence of the phosphoproteins within the *Mononegavirales* order show a large degree of diversity, their function is well conserved. The phosphoproteins, as well as polymerase cofactors from other viral families, serve multiple functions, all of which rely on their ability to interact with the viral polymerase to recruit it to the site of viral replication. Comparison of our structure with that of the recently described severe acute respiratory syndrome coronavirus (SARS-CoV) polymerase complex reveals that the region on the RdRp domain of RSV L that is bound by three of the four P monomers is similar to the region on the SARS-CoV polymerase that is occupied by residues in an N-terminal extension of the polymerase ([Figure S7](#figs7){ref-type="fig"} ; [@bib37]). Perhaps even more strikingly, comparison of the RSV L-P complex structure with the structure of the replicase holoenzyme complex from bacteriophage Qβ also reveals conserved features. During infection in bacteria, Qβ recruits the host-cell ribosomal S1 protein, which is composed of six oligonucleotide-oligosaccharide-binding (OB) domains, to initiate viral replication ([@bib80]). Two of these domains, OB1 and OB2, contact the Qβ replicase core but use different motifs to contact discrete regions and wrap around the replicase core ([@bib33], [@bib73]). Thus, although the structure of S1 and P share no homology, the modular domains of S1 and three of the monomers of P contact similar regions on the finger subdomain of their respective RdRp using a similar strategy ([Figure S7](#figs7){ref-type="fig"}). Contacts made with this region on the RdRp domains of these three viral polymerases may simply act to tether the replication complex and increase the interaction with viral RNA. However, the conserved location of this interface implicates these cofactors in regulating or maintaining the conformation of the replication machinery. This role can be filled by a domain of the polymerase itself (coronavirus), a secondary viral protein (RSV), or even a hijacked host cell protein (Qβ). Future studies will seek to determine how P influences the conformation of RSV L and further clarify the role of this evolutionarily conserved protein-binding interface in viral replication.Figure S7Structural Similarity in Binding Modes of RSV P, SARS-CoV RdRp N-Terminal Extension, and Bacteriophage Qβ Accessory Protein, Related to [Figure 3](#fig3){ref-type="fig"}(A) The RdRp domain of RSV L is shown as ribbons with the fingers colored blue, the thumb in green and the palm in red. All four monomers of P are shown as ribbons and colored orange. (B) The SARS coronavirus RdRp protein (PBD: 6NUR) was superimposed to the RdRp of RSV L using the active site of the palm domains. The RdRp domain is shown as ribbons with the fingers colored blue, the thumb in green, the palm in red, and the N-terminal extension in orange. (C) The RdRp domain of the bacteriophage Qβ replicase (PDB: [4R71](pdb:4R71){#intref0080}) was superimposed to the RdRp of RSV using the active site of the palm domains. The RdRp domain is shown as ribbons with the fingers colored blue, the thumb in green and the palm in red. OB1 and OB2 are shown as ribbons and colored orange.

In addition to the interactions between P and L, our results provide the first structural information for the RdRp and capping domains of RSV L. The structure of the RdRp domain of RSV L is similar to that observed for VSV L ([@bib41]), whereas the PRNTase domains of the two L proteins were observed in different states. In the previously determined VSV L structure, the priming loop was inserted into the RdRp domain, poised to serve a role in initiation. However, in the RSV L structure determined here, the priming loop is flipped away from the RdRp domain of RSV L, suggesting that the conformation identified here represents a non-initiation state and could more closely resemble the elongation conformation of the polymerase. The RSV L structure also rationalizes inhibitor escape mutants and mutations observed in live-attenuated vaccine candidates ([@bib20], [@bib42], [@bib49], [@bib82]). Several of the substitutions that enable escape from nucleoside and non-nucleoside inhibitors appear to allosterically alter the conformation of the inhibitor binding sites, although additional structural studies of inhibitor-bound complexes are needed to fully understand these mechanisms of escape. Atomic-level knowledge of these mechanisms should facilitate the design of antivirals with increased barriers to escape. The RSV L-P structure also provides detailed information for protein-protein interactions that could serve as novel targets for inhibitor development. Thus, our results lay the foundation for the design of novel antivirals and for the improvement of existing small-molecule inhibitors for RSV.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Bacterial and Virus Strains***E. coli* DH10BacThermoFisher ScientificCat\#10361012**Chemicals, Peptides, and Recombinant Proteins**Recombinant Human RSV L-P proteinThis studyN/A^33^P CTPARCCat: ARP 0154-1 mCi^3^H-SAMPerkin-ElmerAdenosyl-L-methionine, S-\[methyl-^3^H\]-. NET155H001MCScintillation fluidPerkin-ElmerBETAPLATE SCINT. Cat\#1205-440DEAE filtermatsPerkin-ElmerCat\#1450-522**Deposited Data**Cryo-EM map of RSV L--P complexThis studyEMDB: EMD-20536Coordinates for RSV L--P complex structureThis studyPDB ID: [6PZK](pdb:6PZK){#intref0010}**Experimental Models: Cell Lines**Spodoptera frugiperda (Sf9)Thermofisher ScientificCAT \# 11496015BSRT7/5Dr KK Conzelmann, Department of Clinical Virology, Federal Research Center for Virus Diseases of Animals, D-72076 Tübingen, Germany.[@bib9].**Oligonucleotides**5′-pACGC[@bib18]<https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0154097>5′-UUUGUUCGCGU[@bib18]<https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0154097>5′-biotin-ACGC[@bib18]<https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0154097>5′-Gppp GGG AC (RSV5), 5′-Gppp GGG ACA AAA (RSV9), 5′-Gppp GGG ACA AAA UGG AUC (RSV15)Dr. Françoise DEBART and Dr. J-Jacques VASSEUR. IBMM, CNRS, Université Montpellier, ENSCM, Campus Triolet, Montpellier, France[@bib55]**Recombinant DNA**pFastbac DualThermofisher ScientificCAT\#10712024pFastbac Dual L-PThis StudyN/ApMT/Luc MinigenomeDr J.-F. Eléouët, VIM, INRA, 78350 Jouy en Josas, France[@bib78]**Software and Algorithms**cryoSPARC v2[@bib59]<https://cryosparc.com/>Chimera[@bib57]<https://www.cgl.ucsf.edu/chimera/>COOT[@bib21]<https://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/>Phenix[@bib1], [@bib2]<https://www.phenix-online.org/>ISOLDE[@bib16]<https://isolde.cimr.cam.ac.uk/what-isolde/>ChimeraX[@bib30]<https://www.rbvi.ucsf.edu/chimerax/>ImageQuant TL v8.1GE Healthcare Life Sciences<http://www.gelifesciences.com/en/us>**Other**Streptavidin FlashplatePerkin ElmerCat\#SMP103A001PKStrep-Tactin Superflow Plus CartridgeQIAGENCat\#30060HiTrap Heparin HPGE HealthcareCat\#17-0406-01Superose 6 IncreaseGE HealthcareCat\#29091596Measuring luciferaseTecan, Männedorf, SwitzerlandInfinite 200 Pro microplate readerGeneration of P mutantsStratageneQuikchange site-directed mutagenesis kit

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for materials should be directed to and will be fulfilled by lead contact Jason S. McLellan (<jmclellan@austin.utexas.edu>).

Method Details {#sec4.3}
--------------

### Protein production and purification {#sec4.3.1}

Human RSV L protein (strain A2) with an N-terminal dual StrepTag and RSV P protein (strain A2) with a C-terminal 6x His-tag were co-expressed in Sf9 insect cells using pFASTbac Dual transfer vector (Life Technologies). The Sf9 cells expressing the L--P polymerase complex were lysed by two passes through a microfluidizer in Strep Buffer A (50 mM Tris-HCl, 300 mM NaCl, 10% glycerol, and 1 mM Tris (2-carboxyethyl) phosphine (TCEP), pH 8.0) supplemented with Complete EDTA-free Protease Inhibitor Cocktail (Roche) and 1 U/mL Benzonase (EMD Millipore). After clarification by high-speed centrifugation, the cell lysate was loaded onto a Strep-Tactin column (QIAGEN), and the bound protein was eluted using 10 mM desthiobiotin in Strep Buffer A. The eluted L--P complex was pooled and diluted with an equal volume of heparin buffer A (50 mM Tris-HCl, 10% glycerol, and 1 mM TCEP, pH 8.0), and was further purified using a heparin column (GE Healthcare). The L--P complex was eluted from the heparin column using a NaCl gradient to a final concentration of 500 mM. The protein was concentrated with an Amicon Ultra centrifugal filter, then loaded on to a size-exclusion column (Superpose 6 Increase 10/300, GE healthcare) equilibrated in 50 mM Tris-HCl, 500 mM NaCl, 10% glycerol, and 1 mM TCEP, pH 8.0. The fractions near the maximum height of the peak were combined, flash-frozen, and stored at −80°C.

### Primer-extension assay {#sec4.3.2}

Primer-extension reactions contained 10 nM RSV L--P complex, incubated with 200 nM RNA (5′-UUUGUUCGCGU) and 4 μM 5′ biotin-labeled RNA primer (5′-biotin-pACGC) mixed in a buffer containing 20 mM Tris-HCl pH 7.5, 10 mM KCl, 6 mM MgCl~2~, 10% dimethyl sulfoxide (DMSO), 2 mM dithiothreitol (DTT), 10 μM GTP, 10 μM ATP, and 25 nM α^33^P-CTP. Each 10 μL reaction was incubated at 30°C for 2 hours and quenched with the addition of 0.1 M EDTA. Quenched reactions were transferred to a Flashplate (Perkin Elmer SMP103A001PK) and incubated for 1 hour at room temperature. The quenched reactions were then washed two times with 0.1% Tween-20, aspirated and read on a Microbeta Trilux (Perkin Elmer).

### Nucleotide-incorporation assay {#sec4.3.3}

Each reaction contained 0.2 μM recombinant RSV L--P, 0.2 μM of an oligonucleotide template sequence derived from the RSV leader promoter (5′ UUUGUUCGCGU 3′) and 400 μM 5′-pACGC primer, mixed in a buffer containing 20 mM Tris-HCl pH 7.5, 10 mM KCl, 2 mM DTT, 0.01% Triton X-100, 10% DMSO, 0.2 U/μL RNasin (Ambion), and 6 mM MgCl~2~. Reactions were started by adding 100 nM α^33^P-GTP tracer with specific NTPs as described in the figure legend to a final volume of 10 μL, and incubated for 30 minutes at 30°C. Reactions were quenched by adding an equal volume of gel-loading buffer (Ambion). Samples were denatured at 95°C for 5 minutes and run on a 22.5% polyacrylamide urea sequencing gel for 1.5 hours at 80 W. The gel was dried, exposed to a phosphor screen, scanned on a Typhoon phosphorimager (GE Healthcare), and quantified using ImageQuant (GE Healthcare).

### MTase activity assay {#sec4.3.4}

The methyltransferase activity was measured using a filter-binding assay, performed according to the method described previously ([@bib55]). A 50 nM solution of RSV L--P complex was incubated with 1.8 μM purified synthetic RNA, 0.17 μM S-adenosyl methionine (SAM) and 0.8 μM ^3^H-SAM (Perkin Elmer) in 50 mM Tris-HCl pH 8.0. After 3 h incubation at 30°C, reactions were quenched by a 20-fold dilution in cold water. Samples were transferred to DEAE filtermats (Perkin Elmer) using a Filtermat Harvester (Packard Instruments). The RNA-retaining mats were washed twice with 10 mM ammonium formate pH 8.0, twice with water and once with ethanol. They were then soaked with scintillation fluid (Perkin Elmer), and ^3^H-methyl transfer to the RNA substrates was determined using a Wallac MicroBeta TriLux Liquid Scintillation Counter (Perkin Elmer).

### RNA synthesis {#sec4.3.5}

RNAs were chemically synthesized on a solid support using the method described previously ([@bib55]). After RNA elongation with 2′ *O*-pivaloyloxymethyl phosphoramidite monomers (Chemgenes, USA), the 5′-hydroxyl group was phosphorylated and the resulting *H*-phosphonate derivative was oxidized and activated into a phosphoroimidazolidate derivative to react with pyrophosphate (pppRNA) or guanosine diphosphate (GpppRNA). After deprotection and release from the solid support, RNA molecules were purified by IEX-HPLC (\> 95% pure) and their identity was confirmed by MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight) spectrometry.

### Cryo-EM data collection {#sec4.3.6}

A cryo-EM dataset of the RSV L--P complex was collected on a Titan Krios operating at 300kV and equipped with a K2 Summit detector. An initial dataset was collected on samples frozen in 1.2/1.3 holey carbon grids, but the resolution was limited to 3.7 Å. In an effort to improve the resolution, a second dataset was collected using UltrAuFoil 1.2/1.3 grids ([@bib66]). UltrAuFoil 1.2/1.3 grids (Electron Microscopy Sciences) were plasma cleaned for 30 s using a Gatan Solarus 950 with a 4:1 O~2~:H~2~ ratio. A 0.57 mg/mL solution of L--P complex in 50 mM Tris-HCl pH 8.0, 500 mM NaCl, 1 mM TCEP and 10% glycerol was diluted with an equal volume of 20 mM Tris-HCl pH 8.0, 200 mM NaCl immediately before 3 μL was deposited onto grids and plunge-frozen in liquid ethane using a Vitrobot Mark IV (Thermo Scientific) set to 100% humidity and 4°C, with a wait time of 0.5 s, a blot time of 4 s and a blot force of 1. Data were collected at 22,500x magnification, corresponding to a calibrated pixel size of 1.075 Å. A total of 30 frames were collected for each micrograph, with defocus values ranging from −1.5 μm to −2.5 μm, a total exposure time of 9 s, and a total electron dose of ∼48 e^−^/Å^2^.

### Cryo-EM data processing {#sec4.3.7}

Motion correction, CTF estimation, template-based picking, 2D classification, heterogeneous 3D refinement, local motion correction, homogeneous 3D refinement, and non-uniform 3D refinement were performed in cryoSPARC v2 ([@bib59], [@bib64], [@bib65], [@bib79]). After motion correction and CTF estimation, a total of 3,144 micrographs were selected for subsequent processing. Template-based picking identified 1,455,759 particles, which was reduced to 622,521 particles after 2D classification and 241,669 particles after two iterative rounds of heterogeneous 3D refinement. Local motion correction was performed on the final particle stack ([@bib65]), followed by homogeneous 3D refinement, which resulted in a 3.4 Å map.

Upon initial building of the L protein model and docking of the closely related hMPV P oligomerization domain structure in our map, it was possible to identify the portions of the map that corresponded to the P protein monomers. We then generated a map in which these regions were deleted using Chimera ([@bib57]). This map, as well as the unmodified map, were low-pass filtered and used as input volumes for a final round of heterogenous 3D refinement to remove particles in which the tetrameric P protein had dissociated. The resulting stack of 196,720 particles was subjected to homogeneous non-uniform 3D refinement that yielded the final 3.2 Å map.

The VSV L structure was used to guide manual building of RSV L ([@bib41]). The map clearly revealed a coiled-coil tetramerization domain, which allowed placement of the hMPV P protein oligomerization domain into our map ([@bib39]). The sharpened map was used for the majority of model building, with the exception of the C-terminal portions of two P monomers, which were built using both the sharpened and unsharpened maps. The region N-terminal to the RdRp Motif A that connects the palm and finger subdomains could not be accurately built in our model, but additional volume likely corresponding to residues ∼665--672 of RSV L was visible in the map. This region is predicted to contain a small α-helix that is visible in the related VSV structure. Manual model building was carried out using Coot ([@bib21]) and refinement of the coordinates was performed using Phenix ([@bib1], [@bib2]). Additional model optimization was performed using ISOLDE ([@bib16]), accessed through ChimeraX ([@bib30]).

### Minigenome assay {#sec4.3.8}

Plasmids for eukaryotic expression of the hRSV N, P, M2-1, and L proteins designated pN, pP, pM2-1 and pL, have been described previously ([@bib25], [@bib77]). The pM/Luc subgenomic minigenome, which encodes the firefly luciferase (Luc) reporter gene under the control of the M/SH gene start sequence, was derived from the pM/SH subgenomic replicon ([@bib34]) and has been described previously ([@bib78]). Point mutations were introduced in pP by site-directed mutagenesis, using the Quikchange site-directed mutagenesis kit (Stratagene). Sequence analysis was carried out to check the integrity of all the constructs. Cells at 90% confluence in 48-well dishes were transfected with a plasmid mixture containing 125 ng of pM/Luc, 125 ng of pN, 125 ng of pP, 62.5 ng of pL, and 31 ng of pM2-1, as well as 31 ng of pRSV-β-Gal (Promega) to normalize transfection efficiencies ([@bib78]). Transfections were done in triplicate, and each independent transfection was performed three times. Cells were harvested 24 h post-transfection, then lysed in luciferase lysis buffer (30 mM Tris-HCl pH 7.9, 10 mM MgCl~2~, 1 mM DTT, 1% Triton X-100, and 15% glycerol). The luciferase activities were determined for each cell lysate with an Infinite 200 Pro (Tecan, Männedorf, Switzerland) and normalized based on β-galactosidase (β-Gal) expression.

Data and Code Availability {#sec4.4}
--------------------------

### Data Resources {#sec4.4.1}

Atomic coordinates for the RSV L--P complex structure have been deposited in the Protein Data Bank and assigned PDB: [6PZK](pdb:6PZK){#intref0070}. Cryo-EM maps have been deposited in the EMDB and assigned code EMD-20536.
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